Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HSPB1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
HSPB1 is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, expressed in. Associated with ALS, Aging, Als. Connected to 177 entities in the SciDEX knowledge graph.
| Gene Symbol | HSPB1 |
| Aliases | Hsp27 |
| Chromosome | 7q11.23. |
| Molecular Weight | 27 kDa |
| Amino Acids | 205 aa |
| Pathways | MAPK Pathway, NF-κB, PI3K |
| GeneCards | HSPB1 |
| Human Protein Atlas | HSPB1 |
| Associated Diseases | Aging, Als, Alzheimer, Cardiovascular, Ms, Multiple Sclerosis |
| Interactions | ALS, CH25H, ATF3, VIM, NEURODEGENERATION, CANCER |
| SciDEX Hypotheses | HSPB1 Phosphorylation Mimetics to Promote Protecti |
| KG Connections | 323 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
HSPB1["HSPB1"]
HSPB1 -.protects against.-> neurodegeneration["neurodegeneration"]
HSPB1 -->|"regulates"| poly_G_aggregates["poly-G aggregates"]
HSPB1 -->|"target for"| Multiple_Sclerosis["Multiple Sclerosis"]
HSPB1 -->|"target for"| Alzheimer["Alzheimer"]
HSPB1 -->|"regulates"| Ms["Ms"]
HSPB1 -->|"target for"| Parkinson["Parkinson"]
HSPB1 -->|"inhibits"| Cancer["Cancer"]
HSPB1 -->|"inhibits"| Als["Als"]
STAT3["STAT3"] -->|"regulates"| HSPB1
CEBPA["CEBPA"] -->|"target for"| HSPB1
HSPA1A["HSPA1A"] -->|"regulates"| HSPB1
TFE3["TFE3"] -->|"target for"| HSPB1
TP53["TP53"] -->|"target for"| HSPB1
SPI1["SPI1"] -->|"target for"| HSPB1
GENES["GENES"] -->|"regulates"| HSPB1
CTSH["CTSH"] -->|"interacts"| HSPB1
COMPLEMENT["COMPLEMENT"] -->|"interacts"| HSPB1| Target | Relation | Type | Str |
|---|---|---|---|
| Apoptosis | inhibits | process | 0.90 |
| Alzheimer's Disease | upregulates | disease | 0.85 |
| Multiple Sclerosis | upregulates | disease | 0.85 |
| Parkinson's Disease | upregulates | disease | 0.85 |
| Apoptosis | suppresses | process | 0.85 |
| Inflammation | activates | disease | 0.75 |
| Neurodegeneration | activates | disease | 0.75 |
| Parkinson | expressed_in | disease | 0.75 |
| neurodegeneration | protects_against | process | 0.70 |
| poly-G aggregates | regulates | process | 0.70 |
| Multiple Sclerosis | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Multiple Sclerosis | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | activates | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Ischemia | activates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Cardiovascular | associated_with | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Multiple Sclerosis | expressed_in | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Alzheimer | protects_against | disease | 0.65 |
| Neurodegeneration | biomarker_for | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Aging | expressed_in | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Sepsis | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Alzheimer | interacts_with | disease | 0.65 |
| Neuroinflammation | interacts_with | disease | 0.65 |
| Inflammation | interacts_with | disease | 0.65 |
| apoptosis | inhibits | phenotype | 0.64 |
| TP53 | therapeutic_target | gene | 0.60 |
| TFE3 | therapeutic_target | gene | 0.60 |
| APOA2 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-ff0d545d | targets_gene | hypothesis | 0.90 |
| SPI1 | regulates | gene | 0.80 |
| CEBPA | regulates | gene | 0.80 |
| HSP90AA1 | regulates | protein | 0.80 |
| STAT3 | regulates | protein | 0.70 |
| INFLAMMATION | activates | gene | 0.70 |
| PARKINSON'S DISEASE | expressed_in | gene | 0.70 |
| NEURODEGENERATION | activates | gene | 0.70 |
| TP53 | regulates | entity | 0.70 |
| CEBPA | therapeutic_target | gene | 0.60 |
| HSPA1A | regulates | gene | 0.60 |
| TFE3 | therapeutic_target | gene | 0.60 |
| TP53 | therapeutic_target | gene | 0.60 |
| SPI1 | therapeutic_target | gene | 0.60 |
| HSPA1A | inhibits | gene | 0.60 |
| GENES | regulates | gene | 0.60 |
| STX4 | associated_with | gene | 0.60 |
| LDLR | associated_with | gene | 0.60 |
| CEBPA | associated_with | gene | 0.60 |
| CTSH | interacts_with | gene | 0.60 |
| COMPLEMENT | interacts_with | gene | 0.60 |
| C1QB | interacts_with | gene | 0.60 |
| ASTROCYTES | activates | gene | 0.60 |
| SOD1 | activates | gene | 0.60 |
| HSP27 | interacts_with | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | activates | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| LGALS3 | associated_with | gene | 0.60 |
| APOA2 | associated_with | gene | 0.60 |
| ANXA2 | activates | gene | 0.60 |
| ICAM1 | activates | gene | 0.60 |
| CD44 | activates | gene | 0.60 |
| HMOX1 | activates | gene | 0.60 |
| SPP1 | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| TIMP1 | activates | gene | 0.60 |
| LGALS3 | activates | gene | 0.60 |
| CD14 | activates | gene | 0.60 |
| RGS1 | activates | gene | 0.60 |
| ZFP36 | activates | gene | 0.60 |
| ICAM1 | associated_with | gene | 0.60 |
| CXCL1 | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 0.60 |
| SOCS3 | associated_with | gene | 0.60 |
| IL6 | associated_with | gene | 0.60 |
| MICROGLIA | therapeutic_target | gene | 0.60 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.60 |
| C5AR1 | associated_with | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| INFLAMMATION | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43 | 0.598 | neurodegeneration | What is the therapeutic window between i |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-12 | 2 hypotheses Top: 0.615
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Heat-shock chaperone HSPB1 mitigates poly-glycine-induced neurodegeneration via [PMID:39936620] | Ding N, Song Y, Zhang Y, Yu W, Li X et a | Autophagy | 2025 | 0 |
| Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection. [PMID:38507480] | Yang F, Beltran-Lobo P, Sung K, Goldrick | Sci Adv | 2024 | 0 |
| crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers tras [PMID:39243601] | Zou Y, Yang A, Chen B, Deng X, Xie J et | Drug Resist Updat | 2024 | 0 |
| HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell dea [PMID:37454220] | Liang Y, Wang Y, Zhang Y, Ye F, Luo D et | Cell Death Dis | 2023 | 0 |
| Integrating single-nucleus sequence profiling to reveal the transcriptional dyna [PMID:37735671] | Fan LY, Yang J, Liu RY, Kong Y, Guo GY e | J Transl Med | 2023 | 0 |
| Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Exp [PMID:35302338] | Ganassi M, Zammit PS | Eur J Transl Myol | 2022 | 0 |
| Heat-shock chaperone HSPB1 regulates cytoplasmic TDP-43 phase separation and liq [PMID:36075972] | Lu S, Hu J, Arogundade OA, Goginashvili | Nat Cell Biol | 2022 | 0 |
| Extracellular vesicle-associated small heat shock proteins as therapeutic agents [PMID:34673130] | Van den Broek B, Wuyts C, Irobi J | Adv Drug Deliv Rev | 2021 | 0 |
| Small heat shock proteins in neurodegenerative diseases. [PMID:32323160] | Vendredy L, Adriaenssens E, Timmerman V | Cell Stress Chaperones | 2020 | 0 |
| The small heat shock proteins, especially HspB4 and HspB5 are promising protecta [PMID:29425965] | Zhu Z, Reiser G | Neurochem Int | 2018 | 0 |